Yew Bio-Pharm Group, Inc., through its operating entity, Harbin Yew Science and Technology Development Co., Ltd (HDS), is a major grower and seller of yew trees and manufacturer of products made from yew trees in China. We also sell raw material, including the branches and leaves of yew trees, used in the manufacture of traditional Chinese medicines (TCMs) which are used as a secondary treatment for certain cancers, meaning it must be administered in combination with other pharmaceutical drugs.
Using a patented accelerated growth technology developed by our founder and President, Zhiguo Wang, based on principles of asexual propagation and cloning, we can bring yew trees to maturity and commercialize them in as little as two-to-three years, compared to more than 50 years needed for naturally grown yew trees
2015 First Quarter Earnings Release
- No Events Currently Scheduled
Founded in 1996 as a state owned enterprise to grow and cultivate yew trees on land near Harbin and incorporated under the laws of the People’s Republic of China.
Became a publicly traded company in the U.S. in 2013
Began trading Over-the-counter in the U.S. under the symbol YEWB
A leading producer of Yew Trees
We have successfully cultivated more than eight million yew nursery seedlings in four nurseries. These nurseries occupy approximately 19,759 Mu (approximately 2,957 acres) of forested land and we currently have the capacity to grow up to two million yew nursery seedlings annually.